An Electronic Pillbox for People With HIV

Status unconfirmed · Phase 1

Conditions studied: HIV Infections

In brief

Anti-HIV drug regimens can be very complicated. This study will evaluate a new electronic pillbox designed to help people take their anti-HIV drugs correctly.

Key facts

Study ID

NCT00071500

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

75

Starts

2003-10-01

Expected to finish

2009-06-01

Last updated by the study team

2008-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-infected for at least six months prior to study entry
• Currently taking at least one and not more than four antiretroviral medications (not including medications for prophylaxis or unrelated disorders)
• Understand the benefits of antiviral medications in reducing viral load, boosting immune response, and preventing opportunistic infections
• Desire to take all antiretroviral medication as scheduled
• Working telephone
• Ambulatory
• Good mental health

You may not qualify if…

• Require assistance dispensing or taking medications
• Require full or part time assistance with the activities of daily living
• Does not intend to take all anti-HIV medication over the course of the study

Where it is running

• LIFETECHniques, Inc. — Santa Barbara, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.